4,265
Views
13
CrossRef citations to date
0
Altmetric
Review Articles

Ultrasound-guided thermal ablation for hyperparathyroidism: current status and prospects

, , &
Pages 466-474 | Received 09 Oct 2021, Accepted 07 Jan 2022, Published online: 10 Mar 2022

References

  • Jawaid I, Rajesh S. Hyperparathyroidism (primary) NICE guideline: diagnosis, assessment, and initial management. Br J Gen Pract. 2020;70(696):362–363.
  • Corbetta S, Mantovani G, Spada A. Metabolic syndrome in parathyroid diseases. Front Horm Res. 2018;49:67–84.
  • Bilezikian JP, Cusano NE, Khan AA, et al. Primary hyperparathyroidism. Nat Rev Dis Primers. 2016;2:16033.
  • Bilezikian JP, Bandeira L, Khan A, et al. Hyperparathyroidism. Lancet. 2018;391(10116):168–178.
  • Melamed ML, Eustace JA, Plantinga L, et al. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int. 2006;70(2):351–357.
  • Tentori F, Wang M, Bieber BA, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. CJASN. 2015;10(1):98–109.
  • Jamal SA, Miller PD. Secondary and tertiary hyperparathyroidism. J Clin Densitom. 2013;16(1):64–68.
  • Dulfer RR, Franssen GJH, Hesselink DA, et al. Systematic review of surgical and medical treatment for tertiary hyperparathyroidism. Br J Surg. 2017;104(7):804–813.
  • Ahmad R, Hammond JM. Primary, secondary, and tertiary hyperparathyroidism. Otolaryngol Clin North Am. 2004;37(4):701–713.
  • Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151(10):959–968.
  • Portillo MR, Rodríguez-Ortiz ME. Secondary hyperparthyroidism: pathogenesis, diagnosis, preventive and therapeutic strategies. Rev Endocr Metab Disord. 2017;18(1):79–95.
  • Neves MCD, Rocha LAD, Cervantes O, et al. Initial surgical results of 500 parathyroidectomies for hyperparathyroidism related to chronic kidney disease – mineral and bone disorder. J Bras Nefrol. 2018;40(4):319–325.
  • Köberle R, Bendik CF. [Primary hyperparathyroidism]. Ther Umsch. 2020;77(9):433–440.
  • National kidney foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4 Suppl 3):S1–S201.
  • Cunningham J, Locatelli F, Rodriguez M. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol. 2011;6(4):913–921.
  • Ketteler M, Block GA, Evenepoel P, et al. Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: synopsis of the kidney disease: improving global outcomes 2017 clinical practice guideline update. Ann Intern Med. 2018;168(6):422–430.
  • Gong L, Tang W, Lu J, et al. Thermal ablation versus parathyroidectomy for secondary hyperparathyroidism: a meta-analysis. Int J Surg. 2019;70:13–18.
  • Hillary S, Balasubramanian SP, et al. Anatomy of the thyroid, parathyroid, pituitary and adrenal glands. Surgery. 2020;38(12):758–762.
  • Lopushniak LY, Khmara ТV, Boichuk ОМ, et al. Fetal anatomy of parathyroid glands. Wiad Lek. 2020;73(1):52–57.
  • Melo C, Pinheiro S, Carvalho L, et al. Identification of parathyroid glands: anatomical study and surgical implications. Surg Radiol Anat. 2015;37(2):161–165.
  • Taterra D, Wong LM, Vikse J, et al. The prevalence and anatomy of parathyroid glands: a meta-analysis with implications for parathyroid surgery. Langenbecks Arch Surg. 2019;404(1):63–70.
  • Spartalis E, Giannakodimos A, Athanasiadis DI, et al. The potential role of carbon nanoparticles in lymph node tracing, recurrent laryngeal nerve identification and parathyroid preservation during thyroid surgery: a systematic review. Curr Pharm Des. 2021;27(21):2505–2511.
  • Fancy T, Gallagher D, 3rd, Hornig JD. Surgical anatomy of the thyroid and parathyroid glands. Otolaryngol Clin North Am. 2010;43(2):221–227.
  • Insogna KL. Primary hyperparathyroidism. N Engl J Med. 2018;379(11):1050–1059.
  • Tokumoto M. [The pathophysiology of secondary hyperparathyroidism]. Clin Calcium. 2016;26(6):821–829.
  • Lee HJ, Seo UH, Kim WY, et al. Calcium-sensing receptor and apoptosis in parathyroid hyperplasia of patients with secondary hyperparathyroidism. J Int Med Res. 2013;41(1):97–105.
  • Mizobuchi M, Ogata H, Koiwa F. Secondary hyperparathyroidism: pathogenesis and latest treatment. Ther Apher Dial. 2019;23(4):309–318.
  • Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin Endocrinol Metab. 2014;99(10):3561–3569.
  • Hamdy NA. Parathyroid gland: is parathyroidectomy safe and beneficial in the elderly? Nat Rev Endocrinol. 2009;5(8):422–423.
  • Komaba H, Shiizaki K, Fukagawa M. Pharmacotherapy and interventional treatments for secondary hyperparathyroidism: current therapy and future challenges. Expert Opin Biol Ther. 2010;10(12):1729–1742.
  • Mauri G, Nicosia L, Della Vigna P, et al. Percutaneous laser ablation for benign and malignant thyroid diseases. Ultrasonography. 2019;38(1):25–36.
  • Gough-Palmer AL, Gedroyc WM. Laser ablation of hepatocellular carcinoma-a review. World J Gastroenterol. 2008;14(47):7170–7174.
  • Ahmed M, Brace CL, Lee FT, Jr, et al. Principles of and advances in percutaneous ablation. Radiology. 2011;258(2):351–369.
  • Dinerman JL, Berger RD, Calkins H. Temperature monitoring during radiofrequency ablation. J Cardiovasc Electrophysiol. 1996;7(2):163–173.
  • Kim JH, Baek JH, Lim HK, et al. 2017 Thyroid radiofrequency ablation guideline: Korean society of thyroid radiology. Korean J Radiol. 2018;19(4):632–655.
  • Park HS, Baek JH, Park AW, et al. Thyroid radiofrequency ablation: updates on innovative devices and techniques. Korean J Radiol. 2017;18(4):615–623.
  • Laeseke PF, Sampson LA, Brace CL, et al. Unintended thermal injuries from radiofrequency ablation: protection with 5% dextrose in water. AJR Am J Roentgenol. 2006;186(5 Suppl):S249–S254.
  • Kim C. Understanding the nuances of microwave ablation for more accurate post-treatment assessment. Future Oncol. 2018;14(17):1755–1764.
  • Sanghvi NT, Hawes RH. High-intensity focused ultrasound. Gastrointest Endosc Clin N Am. 1994;4(2):383–395.
  • Zaltieri M, Massaroni C, Cauti FM, et al. Techniques for temperature monitoring of myocardial tissue undergoing radiofrequency ablation treatments: an overview. Sensors. 2021;21(4):1453.
  • Clement GT. Perspectives in clinical uses of high-intensity focused ultrasound. Ultrasonics. 2004;42(10):1087–1093.
  • Izadifar Z, Izadifar Z, Chapman D, et al. An introduction to high intensity focused ultrasound: systematic review on principles, devices, and clinical applications. JCM. 2020;9(2):460.
  • Elhelf IAS, Albahar H, Shah U, et al. High intensity focused ultrasound: the fundamentals, clinical applications and research trends. Diagn Interv Imaging. 2018;99(6):349–359.
  • Ter HG. HIFU tissue ablation: concept and devices. Adv Exp Med Biol. 2016;880:3–20.
  • Peng C, Zhang Z, Liu J, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation of hyperplastic parathyroid gland for secondary hyperparathyroidism associated with chronic kidney disease. Head Neck. 2017;39(3):564–571.
  • Ying W, Zhen-Long Z, Xiao-Jing C, et al. A study on the causes of operative failures after microwave ablation for primary hyperparathyroidism. Eur Radiol. 2021;31(9):6522–6530.
  • Fukagawa M, Yokoyama K, Koiwa F, et al. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial. 2013;17(3):247–288.
  • Wei Y, Zhuo L, Yu M. A, et al. Expert consensus on thermal ablation for the treatment of secondary hyperparathyroidism (2021 edi-tion). Journal of China-Japan Friendship Hospital. 2021;35(4):195–202.
  • Isakova T, Nickolas TL, Denburg M, et al. KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Am J Kidney Dis. 2017;70(6):737–751.
  • Bennedba KFN, Karstrup S, Hegedüs L. Ultrasound guided laser ablation of a parathyroid adenoma. Br J Radiol. 2001;74(886):905–907.
  • Cusano NE, Lee JA, Wetmore RF, et al. Primary hyperparathyroidism after laser therapy to the larynx. Endocr Pract. 2013;19(5):888–890.
  • Andrioli M, Riganti F, Pacella CM, et al. Long-term effectiveness of ultrasound-guided laser ablation of hyperfunctioning parathyroid adenomas: present and future perspectives. AJR Am J Roentgenol. 2012;199(5):1164–1168.
  • Appelbaum L, Goldberg SN, Ierace T, et al. US-guided laser treatment of parathyroid adenomas. Int J Hyperthermia. 2020;37(1):366–372.
  • Adda G, Scillitani A, Epaminonda P, et al. Ultrasound-guided laser thermal ablation for parathyroid adenomas: analysis of three cases with a three-year follow-up. Horm Res. 2006;65(5):231–234.
  • Hänsler J, Harsch IA, Strobel D, et al. Treatment of a solitary adenoma of the parathyroid gland with ultrasound-guided percutaneous Radio-Frequency-Tissue-Ablation (RFTA). Ultraschall Med. 2002;23(3):202–206.
  • Carrafiello G, Laganà D, Mangini M, et al. Treatment of secondary hyperparathyroidism with ultrasonographically guided percutaneous radiofrequency thermoablation. Surg Laparosc Endosc Percutan Tech. 2006;16(2):112–116.
  • Machi J. Radiofrequency ablation for hyperparathyroidism: can it be a new treatment? Surg Laparosc Endosc Percutan Tech. 2006;16(2):116.
  • Xu SY, Wang Y, Xie Q, et al. Percutaneous sonography-guided radiofrequency ablation in the management of parathyroid adenoma. Singapore Med J. 2013;54(7):e137–e140.
  • Zeng Z, Peng CZ, Liu JB, et al. Efficacy of ultrasound-guided radiofrequency ablation of parathyroid hyperplasia: single session vs. two-session for effect on hypocalcemia. Sci Rep. 2020;10(1):6206.
  • Sormaz IC, Poyanlı A, Açar S, et al. The results of ultrasonography-guided percutaneous radiofrequency ablation in hyperparathyroid patients in whom surgery is not feasible. Cardiovasc Intervent Radiol. 2017;40(4):596–602.
  • Li X, Tufano RP, Russell JO, et al. Ultrasound-guided radiofrequency ablation for the treatment of primary hyperparathyroidism: an efficacy and safety study. Endocr Pract. 2021;27(12):1205–1211.
  • Ha EJ, Baek JH, Baek SM. Minimally invasive treatment for benign parathyroid lesions: treatment efficacy and safety based on nodule characteristics. Korean J Radiol. 2020;21(12):1383–1392.
  • Wei Y, Peng CZ, Wang SR, et al. Microwave ablation versus radiofrequency ablation for primary hyperparathyroidism: a multicenter retrospective study. Int J Hyperthermia. 2021;38(1):1023–1030.
  • Wei Y, Peng CZ, Wang SR, et al. Effectiveness and safety of thermal ablation in the treatment of primary hyperparathyroidism: a multicenter study. J Clin Endocrinol Metab. 2021;106(9):2707–2717.
  • Fan BQ, He XW, Chen HH, et al. US-guided microwave ablation for primary hyperparathyroidism: a safety and efficacy study. Eur Radiol. 2019;29(10):5607–5616.
  • Liu F, Yu X, Liu Z, et al. Comparison of ultrasound-guided percutaneous microwave ablation and parathyroidectomy for primary hyperparathyroidism. Int J Hyperthermia. 2019;36(1):835–840.
  • Wang G, Liu S, Liu X, et al. Microwave ablation: an effective treatment for mild-to-moderate secondary hyperparathyroidism in patients undergoing haemodialysis. Int J Hyperthermia. 2017;33(8):1–952.
  • Yu MA, Yao L, Zhang L, et al. Safety and efficiency of microwave ablation for recurrent and persistent secondary hyperparathyroidism after parathyroidectomy: a retrospective pilot study. Int J Hyperthermia. 2016;32(2):180–186.
  • Zhuo L, Zhang L, Peng LL, et al. Microwave ablation of hyperplastic parathyroid glands is a treatment option for end-stage renal disease patients ineligible for surgical resection. Int J Hyperthermia. 2019;36(1):29–35.
  • Jiang B, Wang X, Yao Z, et al. Microwave ablation vs. parathyroidectomy for secondary hyperparathyroidism in maintenance hemodialysis patients. Hemodial Int. 2019;23(2):247–253.
  • Diao Z, Wang L, Li D, et al. Efficacy of microwave ablation for severe secondary hyperparathyroidism in subjects undergoing hemodialysis. Ren Fail. 2017;39(1):140–145.
  • Hu Z, Han E, Chen W, et al. Feasibility and safety of ultrasound-guided percutaneous microwave ablation for tertiary hyperparathyroidism. Int J Hyperthermia. 2019;36(1):1129–1136.
  • Kovatcheva R, Vlahov J, Stoinov J, et al. US-guided high-intensity focused ultrasound as a promising non-invasive method for treatment of primary hyperparathyroidism. Eur Radiol. 2014;24(9):2052–2058.
  • Kovatcheva RD, Vlahov JD, Shinkov AD, et al. High-intensity focused ultrasound to treat primary hyperparathyroidism: a feasibility study in four patients. AJR Am J Roentgenol. 2010;195(4):830–835.
  • Ambrosini CE, Cianferotti L, Picone A, et al. High-intensity focused ultrasound as an alternative to the surgical approach in primary hyperparathyroidism: a preliminary experience. J Endocrinol Invest. 2011;34(9):655–659.
  • Kovatcheva RD, Vlahov JD, Stoinov JI, et al. High-intensity focussed ultrasound (HIFU) treatment in uraemic secondary hyperparathyroidism. Nephrol Dial Transplant. 2012;27(1):76–80.
  • Puijk RS, Ruarus AH, Scheffer HJ, et al. Percutaneous liver tumour ablation: image guidance, endpoint assessment, and quality control. Can Assoc Radiol J. 2018;69(1):51–62.
  • Cesareo R, Palermo A, Benvenuto D, et al. Efficacy of radiofrequency ablation in autonomous functioning thyroid nodules. A systematic review and meta-analysis. Rev Endocr Metab Disord. 2019;20(1):37–44.
  • Valerio M, Cerantola Y, Eggener SE, et al. New and established technology in focal ablation of the prostate: a systematic review. Eur Urol. 2017;71(1):17–34.